https://www.avient.com/sites/default/files/2023-03/2023 Avient Bookmarked Proxy Statement - FINAL.pdf
Fearon Lead Director of our Board since 2015.
Mink served in this capacity from 2015 to 2020.
Wulfsohn served in this capacity from 2015 to 2019.
https://www.avient.com/sites/default/files/2020-03/polyone-2019-annual-report.pdf
Proud The clear momentum an internally is underpinnin and Performance. 74424.indd main_5 3/16/20 12:25 PM Annual Report | 2019 6 P R O D U C T S 4424_NARc5.indd main_6 3/17/20 12:52 PM 7 Annual Report | 20197 Annual RepRe ort | 2012 9 0% 20% 40% 60% 80% 100% 2005 2010 2015 2019 PF** $14M $117M $273M $500M Over 85% of Adjusted EBITDA from Specialty % o f A d ju s te d E B IT D A * * Adjusted EBITDA is EBITDA excluding corporate costs and special items **2019E Pro Forma for the acquisition of Clariant’s Masterbatch business with synergies of $60M and the divestiture of our PP&S segment using 2018 financial information Specialty EBITDA Distribution $14M 87% 66% 46% 7% Since 2006 when we began our transformation to become a specialty company, we have been refining our portfolio of solutions and services to best serve our customers.
D O L L A R S *Pro Forma for sale of DSS 2009 2010 2011 2012 2013 2014 2015 2016* 2017* 2018 2018 2019 $2.21 $0.13 $0.68 $0.82 $1.00 $1.31 $1.80 $2.43 $2.06 $1.96 Pro Forma for sale of PP&S $1.69 $1.51 12 31 2018 3 31 2019 6 30 2019 9 30 2019 12 31 2019 +32% 2019 POL Stock Price Performance $ U .S .
SHAREHOLDER INQUIRIES If you have any questions concerning your account as a shareholder, name or address changes, inquiries regarding stock certificates, or if you need tax information regarding your account, please contact our transfer agent: Equiniti Trust Company 1110 Centre Pointe Curve, Suite 101 Mendota Heights, MN 55120-4100 Phone: 1-855-598-2615 or 1-651-450-4064 www.shareowneronline.com Additional information about PolyOne, including current and historic copies of Annual Reports on Form 10-K and other reports filed with the Securities and Exchange Commission, is available online at www.polyone.com or free of charge from: Investor Affairs Relations PolyOne Corporation 33587 Walker Road Avon Lake, Ohio 44012 Phone: 440-930-1000 ANNUAL MEETING The annual meeting of shareholders of PolyOne will be held May 14, 2020 at 9:00 a.m. at PolyOne’s Corporate headquarters, 33587 Walker Road, Avon Lake, Ohio.
https://www.avient.com/sites/default/files/2023-09/Avient Sustainability Day 2023 - Website %289.19%29.pdf
DISCLAIMER Avient Corporation 3 Avient Corporation 4 Welcome Bob Patterson Chairman, President, and Chief Executive Officer INTRODUCTION Sustainability for a Better Tomorrow Jamie Beggs Senior Vice President and Chief Financial Officer Avient Corporation 5 WE ARE A FORMULATOR CUSTOM FORMULATION Avient Corporation 6 Avient Corporation 7 WE ARE INNOVATORS 2,500+ ACTIVE PATENT FILINGS WORLDWIDE 1,100+ RESEARCH AND DEVELOPMENT ASSOCIATES >85% Stage-gate technology projects enable sustainable solutions INDIA INNOVATION CENTER 33% 2022 VITALITY INDEX 140+ MATERIAL SCIENCE PhD ASSOCIATES Avient Corporation 8 3% 3% 5% Avient Specialty Formulators Other Specialty / Chemical Companies CAPEX / Revenue 2023E Global footprint enables greater flexibility to exceed needs of customers and deliver localized technical and formulation expertise 35 9 36 24 Manufacturing Locations by Region WE ARE ASSET LIGHT Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA Avient Corporation 9 Asset-light flexibility enables more nimble manufacturing capabilities and lower overhead Periods of economic weakness have driven higher levels of cash generation due to working capital improvement PROVEN TRACK RECORD OF HIGH FREE CASH FLOW CONVERSION 78% 78% 80% 80% 81% 78% 84% 83% 80% 79% 50% 55% 60% 65% 70% 75% 80% 85% 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023E 0 50 100 150 200 250 300 350 400 Fr ee C as h Fl ow C on ve rs io n Fr ee C as h Fl ow FCF $ AVNT FCF Conversion % S&P FCF Conversion % 2 Recent Divestitures - Combined $1.7B in Proceeds PORTFOLIO EVOLUTION Avient Corporation 10 Combined $3.6B Investment in Acquisitions Since 2016 Color Business Distribution 2016 2022 PORTFOLIO TRANSFORMATION 7% 46% 66% 87% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2015 2020 2023 % o f A dj us te d EB IT DA Commodity JVs Distribution Performance Products & Solutions Specialty Businesses Adjusted EBITDA from Specialty Applications Avient Corporation 11 END MARKET TRANSFORMATION Packaging Consumer Healthcare Defense Avient Corporation 12 10% 19% 8% 23% 4% 7% 7% 2006 2023E Other Industri es 78% Healthcare Consumer Packaging 22% 56% 14% 10% 43% 9% 2006 2023E Reduced Exposure to Cyclical End Markets End Market Diversification Transportation Building & Construction 57% 19% Defense IMPROVING PROFITABILITY AND EXPANDING MARGINS Avient Corporation 13 Adj.
Per Carlsson, Manufacturing and Operations CUSTOMER TESTIMONIALS Avient Corporation 71 50 90 0 20 40 60 80 100 2022 2030 Medical Plastics Market Size PRESERVE – TAKEAWAY Protecting Human Life and Enabling Connectivity Drives Growth Projections Examples Covered Today 56% Other Applications 44% 2022 $525M (in $ Bi lli on s) 8% CAGR 34% CAGR 5G Infrastructure Market Size 12 92 0 10 20 30 40 50 60 70 80 90 100 2023 2024 2025 2026 2027 2028 2029 2030 (in $ Bi lli on s) Source: Grand View Research Source: Global Data Summary Jamie Beggs Senior Vice President and Chief Financial Officer Avient Corporation 72 OUR SUSTAINABILITY REPORT Avient Corporation 73 Avient Corporation 74 2030 SUSTAINABILITY GOALS Avient Corporation 75 PERFORMANCE AND RECOGNITION 1 2 5 ESG Ratings Performance ESG Awards and Certifications top 13% 94th percentile Avient Corporation 76 SUSTAINABILITY INNOVATION AWARDS Ultra-Low Carbon Footprint TPE Innovation Award, Finalist: Plastics Industry Association PCR Colorants + Additives Sustainable Packaging Innovation, Finalist: U.S.
https://www.avient.com/sites/default/files/2025-04/Supplier Code of Conduct FV_Spanish.pdf
§ 1307) y la Ley de Facilitación y Aplicación del Comercio de 2015 (TFTEA), las disposiciones aplicables de la Ley de Prevención del Trabajo Forzoso Uigur (UFLPA), las disposiciones sobre esclavitud moderna y trata de seres humanos de la Ley de Esclavitud Moderna de 2015 del Reino Unido, y las Líneas Directrices de la OCDE para Empresas Multinacionales.
https://www.avient.com/sites/default/files/2022-08/Avient Candidates Data Privacy Notice Final - French.pdf
Avient peut traiter vos informations personnelles lorsque cela est nécessaire pour ses intérêts légitimes (sauf si vos intérêts ou vos droits et libertés fondamentaux l'emportent sur ceux-ci), y compris : • Pour gérer les obligations en matière de tenue de registres et de rapports dans le cadre de son vivier de candidats ; • Pour traiter les remboursements de toutes les dépenses encourues pour les déplacements pendant la procédure d'entretien ; • Pour partager les informations avec les sociétés affiliées d'Avient conformément à la présente déclaration, si nécessaire à des fins de gestion globale ; et • Pour respecter les lois et règlements en vigueur.
Le délégué à la protection des données d'Avient peut être contacté à l'adresse suivante : PRIVACY.OFFICER@AVIENT.COM. ** Pour les candidats au Pérou, les informations personnelles seront stockées dans la banque de données « [avient.taleo.net] » enregistrée dans le Registre national de protection des données personnelles avec le code RNPDP-PJP Nº [*].
https://www.avient.com/sites/default/files/2023-07/Versaflex HC _ Versaflex HC BIO - BT Series Product Overview.pdf
KEY CHARACTERISTICS • Meets critical need for thermal weldability and kink resistance • Minimizes extractables during processing • Provides excellent tensile strength • Complies with USP VI and ISO 10993-4, -5, -11 certifications • Suitable for gamma and autoclave sterilization methods • Bio-based grade option formulated with nearly 40% Gen 1 biomass content PRODUCT OVERVIEW 1.844.4AVIENT www.avient.com Copyright © 2023, Avient Corporation.
https://www.avient.com/sites/default/files/2020-05/2.-polyone-ir-presenstation-wells-fargo-industrials-conference.pdf
Microsoft PowerPoint - PolyOne Investor Presentation 5.4.20_v8 • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • P E O P LE P RO D U CT S P LA N E T P E RF O R MAN C E •• •• •• JVs Performance Products & Solutions Distribution Specialty To be the world’s premier provider of specialized polymer materials, services and solutions To be the world’s premier provider of specialized polymer materials, services and sustainable solutions • • • • • • • • • • • • • • 2016 2017 2018 2019 Lightweighting Reduced Material Requirements Improved Recyclability Renewable Energy Applications Eco-conscious Bio-derived Content Reduced Energy Use VOC Reduction $275M $325M $355M $410M 14% Total Annual Growth 9% Organic Annual Growth PolyOne Corporation 33 Adjusted EPS attributable to PolyOne common shareholders is calculated as follows: 2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016** 2017** 2018 2018*** Q1 2019*** 2019 Q1 2020 Net income from continuing operations attributable to PolyOne common shareholders Joint venture equity earnings, after tax Special items, before tax(1) Special items, tax adjustments(1) Adjusted net income from continuing operations attributable to PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 $ 161.1 $ 87.7 $ 22.4 $ 75.5 $ 33.1 (19.0) (14.7) (3.7) — — — — — — — — — — — (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 59.5 58.7 12.2 61.7 9.6 (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) (25.3) (25.1) (1.2) (5.9) (1.0) $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 $ 195.3 $ 121.3 $ 33.4 $ 131.3 $ 41.7 Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 80.4 80.4 78.2 77.7 86.7 Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 $ 2.43 $ 1.51 $ 0.43 $ 1.69 $ 0.48 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation. ** Pro forma for sale of Designed Structures and Solutions segment (DSS). *** Pro forma for sale of Performance Products and Solutions segment (PP&S).
https://www.avient.com/sites/default/files/2020-08/gravi-tech-closures-case-study-spanish.pdf
De hecho, un informe llamado “El empaque importa” (Packaging Matters™) realizado en 2015 por la compañía MeadWestvaco, indica que más del 25% de los consumidores de bebidas alcohólicas dicen que el empaque es “muy” o “extremadamente” impactante en su decisión de compra de un producto.
https://www.avient.com/sites/default/files/2020-05/1.-polyone-ir-presenstation-fermium-research-chemicals-conference.pdf
Microsoft PowerPoint - PolyOne Investor Presentation 5.4.20_v8 • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • P E O P LE P RO D U CT S P LA N E T P E RF O R MAN C E •• •• •• JVs Performance Products & Solutions Distribution Specialty To be the world’s premier provider of specialized polymer materials, services and solutions To be the world’s premier provider of specialized polymer materials, services and sustainable solutions • • • • • • • • • • • • • • 2016 2017 2018 2019 Lightweighting Reduced Material Requirements Improved Recyclability Renewable Energy Applications Eco-conscious Bio-derived Content Reduced Energy Use VOC Reduction $275M $325M $355M $410M 14% Total Annual Growth 9% Organic Annual Growth PolyOne Corporation 33 Adjusted EPS attributable to PolyOne common shareholders is calculated as follows: 2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016** 2017** 2018 2018*** Q1 2019*** 2019 Q1 2020 Net income from continuing operations attributable to PolyOne common shareholders Joint venture equity earnings, after tax Special items, before tax(1) Special items, tax adjustments(1) Adjusted net income from continuing operations attributable to PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 $ 161.1 $ 87.7 $ 22.4 $ 75.5 $ 33.1 (19.0) (14.7) (3.7) — — — — — — — — — — — (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 59.5 58.7 12.2 61.7 9.6 (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) (25.3) (25.1) (1.2) (5.9) (1.0) $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 $ 195.3 $ 121.3 $ 33.4 $ 131.3 $ 41.7 Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 80.4 80.4 78.2 77.7 86.7 Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 $ 2.43 $ 1.51 $ 0.43 $ 1.69 $ 0.48 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation. ** Pro forma for sale of Designed Structures and Solutions segment (DSS). *** Pro forma for sale of Performance Products and Solutions segment (PP&S).
https://www.avient.com/sites/default/files/2022-09/Cesa Aversive Product Bulletin.pdf
Reference Product Name Carrier CC10087477BG 87477 EVA Anti-Rat Masterbatch EVA CC10107079BG 107079 EVA Anti-Termite Masterbatch EVA CC10125842BG 5842 EVA Multi-Repel Masterbatch EVA VALUE SOLUTION The European Union adopted Guidelines in 2015 establishing that masterbatches with biocidal function needed to be authorized for use in European Union.1 As such, masterbatch products containing aversive or repellent substances are considered as a biocidal product.2 Indeed, deterring harmful organisms is a biocidal function.